These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1948818)

  • 1. Subunit composition of plasma von Willebrand factor multimers: evidence for a non-proteolytic mechanism resulting in apparent increase in proteolytic fragments.
    Tsai HM; Nagel RL; Sussman II
    Thromb Res; 1991 Jul; 63(1):179-88. PubMed ID: 1948818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
    Dent JA; Galbusera M; Ruggeri ZM
    J Clin Invest; 1991 Sep; 88(3):774-82. PubMed ID: 1909351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage.
    Berkowitz SD; Federici AB
    Blood; 1988 Nov; 72(5):1790-6. PubMed ID: 2460162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.
    Tsai HM
    Blood; 1996 May; 87(10):4235-44. PubMed ID: 8639782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma.
    Tsai HM; Sussman II; Nagel RL
    Blood; 1994 Apr; 83(8):2171-9. PubMed ID: 8161783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.
    Federici AB; Elder JH; De Marco L; Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1984 Dec; 74(6):2049-55. PubMed ID: 6239876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triplet structure of human von Willebrand factor.
    Fischer BE; Thomas KB; Schlokat U; Dorner F
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):483-8. PubMed ID: 9531488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human von Willebrand factor: a multivalent protein composed of identical subunits.
    Chopek MW; Girma JP; Fujikawa K; Davie EW; Titani K
    Biochemistry; 1986 Jun; 25(11):3146-55. PubMed ID: 3015199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of von Willebrand factor in therapeutic plasma concentrates.
    Mannuccio PM; Lattuada A; Ruggeri ZM
    Blood; 1994 May; 83(10):3018-27. PubMed ID: 8180399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease.
    Berkowitz SD; Nozaki H; Titani K; Murachi T; Plow EF; Zimmerman TS
    Blood; 1988 Aug; 72(2):721-7. PubMed ID: 2840990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new variant of von Willebrand disease (type II I) with a normal degree of proteolytic cleavage of von Willebrand factor.
    Castaman G; Rodeghiero F; Lattuada A; Mannucci PM
    Thromb Res; 1992 Feb; 65(3):343-51. PubMed ID: 1631800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).
    Zimmerman TS; Dent JA; Ruggeri ZM; Nannini LH
    J Clin Invest; 1986 Mar; 77(3):947-51. PubMed ID: 3485111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.
    Levene RB; Booyse FM; Chediak J; Zimmerman TS; Livingston DM; Lynch DC
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6550-4. PubMed ID: 3306682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.
    Bockenstedt P; Greenberg JM; Handin RI
    J Clin Invest; 1986 Mar; 77(3):743-9. PubMed ID: 2936763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Mannucci PM; Lombardi R; Lattuada A; Ruggenenti P; Viganò GL; Barbui T; Remuzzi G
    Blood; 1989 Aug; 74(3):978-83. PubMed ID: 2665869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.